Jingsong Zhang, M.D., Ph.D.

Trials

Studies that name Jingsong Zhang, M.D., Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:38 UTC. Open this list on ClinicalTrials.gov

• Early Ph1
  NCT03511196 · Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

  H. Lee Moffitt Cancer Center and Research Institute · active not recruiting · Prostate Cancer, Stage IV Prostate Cancer, Advanced Prostate Cancer · principal investigator
• N/A
  NCT02981797 · Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

  H. Lee Moffitt Cancer Center and Research Institute · completed · Prostate Cancer, Prostate Adenocarcinoma · principal investigator
• Ph2
  NCT02901548 · Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder

  H. Lee Moffitt Cancer Center and Research Institute · terminated · Carcinoma in Situ of Bladder, Bladder Cancer · principal investigator
• Early Ph1
  NCT02415621 · Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer

  H. Lee Moffitt Cancer Center and Research Institute · completed · Prostate Cancer · principal investigator
• Ph1
  NCT02300610 · Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

  H. Lee Moffitt Cancer Center and Research Institute · completed · Bladder Cancer, Carcinoma, Transitional Cell, Renal Pelvis Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.